There have been nearly 6,000 U.S. mergers and acquisitions since last fall, with deals totaling $656 billion, according to Dealogic, a research and investing information company. That wave represents the highest September-to-March tally since Dealogic started tracking mergers and acquisitions in 1995, officials said.
The NuVasive deal signals that company’s move into full-scale implant manufacturing and creates a long-term opportunity to improve profitability, officials said.
NuVasive has been involved with ANC since 2010, and the latter company currently is one of NuVasive’s significant implant suppliers, officials said.
“Bringing portions of our manufacturing in house is a key element of our ongoing commitment to improve operating profitability as we grow toward $1 billion in revenue and beyond,” said Alex Lukianov, NuVasive’s chairman and chief executive, in a statement.
NuVasive officials said they plan to expand ANC’s capacity and systems. ANC President Don Knoth could not be reached for comment.
NuVasive develops minimally disruptive surgical products and procedures for the spine. NuVasive is the third-largest spine company in the U.S., and the fourth-largest globally. The company had revenue of $620.3 million for 2012 and employs more than 1,500 people. The global spine market is worth $8.2 billion annually, officials said.
About the Author